# A Feasibility Study to Assess the Use of Gadolinium in Computed Tomography

> **NCT02163005** · PHASE4 · WITHDRAWN · sponsor: **Massachusetts General Hospital**

## Conditions studied

- Contrast Media Allergy

## Interventions

- **DRUG:** Gadolinium

## Key facts

- **NCT ID:** NCT02163005
- **Lead sponsor:** Massachusetts General Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2016-12
- **Primary completion:** 2018-12
- **Final completion:** 2018-12
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** No patients enrolled as study did not move to enrollment stage
- **Last updated:** 2021-05-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02163005

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02163005, "A Feasibility Study to Assess the Use of Gadolinium in Computed Tomography". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT02163005. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*